Phase II LAPACT trial of nab-paclitaxel (nab-P) plus gemcitabine (G) for patients with locally advanced pancreatic cancer (LAPC).
暂无分享,去创建一个
P. Philip | J. Lacy | P. Hammel | S. Dowden | T. Nydam | A. Sobrero | T. Ong | F. Portales | É. Terrebonne | R. P. Cid | Jack Shiansong Li | R. P. Pazo Cid | J. M. Manzano Mozo | Jack Shiansong Li | J. Mozo | J. Li